Form 4 holding
EVP, Clinical Development
Celularity Inc
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 125,000
- Estimated value
- Report date
- 13 Sep 2021
- Price
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount